{"id":"https://openalex.org/W1993633682","doi":"https://doi.org/10.1097/00002030-200102160-00019","title":"Drug interaction between St John's wort and nevirapine","display_name":"Drug interaction between St John's wort and nevirapine","publication_year":2001,"publication_date":"2001-02-01","ids":{"openalex":"https://openalex.org/W1993633682","doi":"https://doi.org/10.1097/00002030-200102160-00019","mag":"1993633682","pmid":"https://pubmed.ncbi.nlm.nih.gov/11273226"},"language":"en","primary_location":{"id":"doi:10.1097/00002030-200102160-00019","doi":"https://doi.org/10.1097/00002030-200102160-00019","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-200102160-00019","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025247005","display_name":"Monique M. R. de Maat","orcid":"https://orcid.org/0000-0002-1009-1263","observed_orcids":["https://orcid.org/0000-0002-1009-1263"]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Monique M. R. de Maat","raw_affiliation_strings":["Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands","Pharmacy and Pharmacology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802065108"]},{"raw_affiliation_string":"Pharmacy and Pharmacology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030426323","display_name":"Richard M. W. Hoetelmans","orcid":"https://orcid.org/0000-0001-5582-3627","observed_orcids":["https://orcid.org/0000-0001-5582-3627"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard M. W. Hoetelmans","raw_affiliation_strings":["Pharmacy and Pharmacology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy and Pharmacology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021986417","display_name":"Ron A. A. Math\u00f4t","orcid":"https://orcid.org/0000-0001-8401-0879","observed_orcids":["https://orcid.org/0000-0001-8401-0879"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ron A. A. Math\u00f4t","raw_affiliation_strings":["Pharmacy and Pharmacology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy and Pharmacology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038465935","display_name":"Eric C. M. Van Gorp","orcid":"https://orcid.org/0000-0001-6415-6678","observed_orcids":["https://orcid.org/0000-0001-6415-6678"]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Eric C. M. van Gorp","raw_affiliation_strings":["Internal Medicine, Slotervaart Hospital, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Slotervaart Hospital, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802065108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110233425","display_name":"Pieter L. Meenhorst","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Pieter L. Meenhorst","raw_affiliation_strings":["Internal Medicine, Slotervaart Hospital, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Slotervaart Hospital, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802065108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102945216","display_name":"Jan Willem Mulder","orcid":"https://orcid.org/0000-0002-9768-3797","observed_orcids":["https://orcid.org/0000-0002-9768-3797"]},"institutions":[{"id":"https://openalex.org/I2802065108","display_name":"Slotervaartziekenhuis","ror":"https://ror.org/01w502745","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802065108"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jan W. Mulder","raw_affiliation_strings":["Internal Medicine, Slotervaart Hospital, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Slotervaart Hospital, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802065108"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062227574","display_name":"Jos H. Beijnen","orcid":"https://orcid.org/0000-0003-0118-561X","observed_orcids":["https://orcid.org/0000-0003-0118-561X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos H. Beijnen","raw_affiliation_strings":["Pharmacy and Pharmacology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy and Pharmacology, and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":11.0477,"has_fulltext":false,"cited_by_count":176,"citation_normalized_percentile":{"value":0.98926998,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"15","issue":"3","first_page":"420","last_page":"421"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.4097000062465668,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.4097000062465668,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.17409999668598175,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12087","display_name":"Natural Compound Pharmacology Studies","score":0.12160000205039978,"subfield":{"id":"https://openalex.org/subfields/1110","display_name":"Plant Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypericum-perforatum","display_name":"Hypericum perforatum","score":0.9959999918937683},{"id":"https://openalex.org/keywords/nevirapine","display_name":"nevirapine","score":0.9909999966621399},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.7749999761581421},{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.7080000042915344},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9240000247955322},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.7889999747276306},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.8109999895095825},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.8389999866485596},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.3310000002384186},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.5799999833106995},{"id":"https://openalex.org/keywords/nonlinear-mixed-effects-modelling","display_name":"nonlinear mixed-effects modelling","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C2776651039","wikidata":"https://www.wikidata.org/wiki/Q158289","display_name":"Hypericum perforatum","level":2,"score":0.8024297952651978},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7314427495002747},{"id":"https://openalex.org/C2777210460","wikidata":"https://www.wikidata.org/wiki/Q425490","display_name":"Indinavir","level":5,"score":0.7002512216567993},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.6388247013092041},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.5870616436004639},{"id":"https://openalex.org/C2780345285","wikidata":"https://www.wikidata.org/wiki/Q414762","display_name":"Etravirine","level":5,"score":0.5600554943084717},{"id":"https://openalex.org/C2781064554","wikidata":"https://www.wikidata.org/wiki/Q407883","display_name":"Ketoconazole","level":3,"score":0.5182092785835266},{"id":"https://openalex.org/C2779182219","wikidata":"https://www.wikidata.org/wiki/Q3765251","display_name":"Darunavir","level":5,"score":0.5071306228637695},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.47236257791519165},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4520258605480194},{"id":"https://openalex.org/C2777707475","wikidata":"https://www.wikidata.org/wiki/Q422222","display_name":"Digoxin","level":3,"score":0.44653618335723877},{"id":"https://openalex.org/C2778350159","wikidata":"https://www.wikidata.org/wiki/Q412742","display_name":"Hyperforin","level":3,"score":0.4432111382484436},{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.41890978813171387},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41462522745132446},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3663244843482971},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2259933054447174},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.15225282311439514},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13964125514030457},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.13756921887397766},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0731472373008728},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.0},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.0},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008517","descriptor_name":"Phytotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010936","descriptor_name":"Plant Extracts","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010946","descriptor_name":"Plants, Medicinal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020902","descriptor_name":"Hypericum","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00002030-200102160-00019","doi":"https://doi.org/10.1097/00002030-200102160-00019","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-200102160-00019","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:11273226","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11273226","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W2008263033","https://openalex.org/W2027350291","https://openalex.org/W2034774522","https://openalex.org/W2127645257","https://openalex.org/W2171287195"],"related_works":["https://openalex.org/W2197831775","https://openalex.org/W2266708814","https://openalex.org/W2903682466","https://openalex.org/W2170492741","https://openalex.org/W2142244531","https://openalex.org/W2016943134","https://openalex.org/W2091017939","https://openalex.org/W1967782384","https://openalex.org/W7055448440","https://openalex.org/W2165016043"],"abstract_inverted_index":{"Cases":[0],"have":[1,162,478,524],"been":[2,107,251],"reported":[3,405],"that":[4,6,142,316,476,526],"suggest":[5],"extracts":[7,135,151],"from":[8,284],"St":[9,51,68,182,220,272,309,342,423,456,498,527,564],"John's":[10,52,69,183,221,273,310,343,424,457,499,528,565],"wort":[11,70,222,274,311,425,500,529,566],"(Hypericum":[12],"perforatum),":[13],"mainly":[14],"used":[15,271,473],"as":[16,109,312,427],"an":[17,140,403,481],"antidepressant":[18],"[1],":[19],"contain":[20],"potent":[21],"inducers":[22],"of":[23,29,50,56,59,63,81,121,124,133,147,170,181,187,219,231,321,341,357,362,376,422,441,466,497,513,516,561],"hepatic":[24],"enzymes,":[25],"raising":[26],"the":[27,42,47,57,60,64,72,75,89,122,125,131,145,178,188,202,211,216,254,317,339,419,434,438,467,491,494,504,531,534,558],"possibility":[28],"clinically":[30,111],"relevant":[31],"drug":[32,44],"interactions.":[33],"Recent":[34],"pharmacokinetic":[35,436],"data":[36],"show":[37],"substantially":[38],"decreased":[39,88,137,164,168,226,463],"exposure":[40,227,532,545],"to":[41,155,228,461,533,546],"antiretroviral":[43,232,552],"indinavir":[45,82],"by":[46,83,95,338,537],"concomitant":[48,179,217,420,495,559],"use":[49,180,218,340,421,496,560],"wort,":[53,344,458],"probably":[54],"because":[55],"induction":[58,120],"3A4":[61],"isoform":[62],"cytochrome":[65,212],"P450":[66,213],"system.":[67],"reduced":[71],"area":[73],"under":[74],"plasma":[76,165,282,301,319,360],"concentration":[77,94,302],"versus":[78],"time":[79],"curve":[80],"57%":[84],"(SD":[85,97],"19%),":[86],"and":[87,175,193,257,268,304,387,409,415,554,563],"extrapolated":[90],"8":[91],"h":[92],"trough":[93],"81%":[96],"16%)":[98],"in":[99,225,400,433,470,480,506,518,551],"eight":[100],"healthy":[101],"volunteers":[102],"[2].":[103],"This":[104],"interaction":[105,114],"has":[106],"recognized":[108],"being":[110],"relevant.":[112],"An":[113],"study":[115],"[3]":[116],"with":[117,129,144,177,234,247,253,303,380,384,402,446],"digoxin":[118,138],"suggested":[119],"expression":[123],"drug-transporter":[126],"P-glycoprotein.":[127],"Compared":[128],"placebo,":[130],"co-administration":[132],"Hypericum":[134,150],"significantly":[136,444],"concentrations,":[139],"effect":[141],"increased":[143,445,482],"number":[146],"days":[148],"on":[149,327],"[3].":[152],"In":[153,521],"addition":[154],"such":[156],"studies,":[157],"several":[158,276],"case":[159],"reports":[160],"[4]":[161],"shown":[163,525],"concentrations":[166,283,320,361],"or":[167],"activity":[169],"cyclosporin,":[171],"oral":[172,393,431,439,483,507,514,540],"contraceptives,":[173],"theophylline":[174],"warfarin":[176],"wort.":[184],"As":[185,485],"all":[186],"currently":[189],"marketed":[190],"protease":[191],"inhibitors":[192,197,263],"non-nucleoside":[194],"reverse":[195,261],"transcriptase":[196,262],"(NNRTI)":[198],"are":[199,207,287],"substrates":[200],"for":[201,264,275,371,430,453],"multidrug":[203],"transporter":[204],"P-glycoprotein":[205],"and/or":[206],"extensively":[208,488],"metabolized":[209,489],"via":[210,490],"enzyme":[214],"system,":[215,493],"may":[223,548],"result":[224,550],"these":[229,322,333],"classes":[230],"drugs,":[233],"clinical":[235],"consequences.":[236],"We":[237,314],"present":[238],"five":[239,294,468],"patients":[240,295,323,454,469],"(all":[241],"men,":[242],"aged":[243],"34\u201353":[244],"years)":[245],"infected":[246],"HIV-1,":[248],"who":[249,269],"had":[250,296],"treated":[252],"NNRTI":[255,535],"nevirapine":[256,281,300,318,359,377,442,486,517,536,547,562],"two":[258],"nucleoside":[259],"analogue":[260],"over":[265],"a":[266,345,381,428,462,543],"year,":[267],"concomitantly":[270],"months.":[277,292],"At":[278],"our":[279,471],"clinic,":[280],"each":[285],"patient":[286],"routinely":[288],"measured":[289],"every":[290],"3":[291],"The":[293,374,391],"at":[297,305],"least":[298,306],"one":[299,307],"without":[308],"co-medication.":[313],"noticed":[315],"were":[324,336,378,413],"consistently":[325],"lower":[326,334],"some":[328],"occasions.":[329],"To":[330],"determine":[331],"whether":[332],"exposures":[335],"caused":[337],"non-linear":[346],"mixed-effect":[347],"modelling":[348],"analysis":[349],"(NONMEM)":[350],"was":[351,369,395,443],"performed":[352],"[5].":[353],"A":[354],"database":[355],"consisting":[356],"1330":[358],"176":[363],"patients,":[364],"collected":[365],"during":[366],"789":[367],"visits,":[368],"available":[370],"this":[372],"analysis.":[373],"pharmacokinetics":[375],"described":[379],"one-compartment":[382],"model":[383],"first-order":[385],"absorption":[386],"elimination":[388],"(Table":[389],"1).":[390],"median":[392],"clearance":[394,432,440,515],"3.2":[396],"l/h,":[397],"which":[398],"is":[399,487],"accordance":[401],"earlier":[404],"value":[406],"[6].":[407],"Interindividual":[408],"interoccasion":[410],"(intervisit)":[411],"variability":[412],"29":[414],"22%,":[416],"respectively.":[417],"With":[418],"included":[426],"co-variate":[429],"population":[435,472],"model,":[437],"35%":[447],"(SE":[448],"15%)":[449],"(P":[450],"=":[451],"0.02)":[452],"using":[455],"thus":[459],"leading":[460],"exposure.":[464],"None":[465],"any":[474],"co-medication":[475],"could":[477],"resulted":[479],"clearance.":[484,541],"CYP450":[492],"can":[501],"therefore":[502],"explain":[503],"increase":[505],"clearance.Table":[508],"1:":[509],"Median":[510],"individual":[511],"estimates":[512],"HIV-1-infected":[519],"patients.":[520],"conclusion,":[522],"we":[523],"decreases":[530],"increasing":[538],"its":[539],"Because":[542],"low":[544],"eventually":[549],"resistance":[553],"treatment":[555],"failure":[556],"[7],":[557],"should":[567],"be":[568],"avoided.":[569],"Monique":[570],"M.":[571,576,585],"R.":[572],"de":[573],"Maata":[574],"Richard":[575],"W.":[577,592],"Hoetelmansa":[578],"Ron":[579],"A.":[580,581],"Math\u00f4ta":[582],"Eric":[583],"C.":[584],"van":[586],"Gorpb":[587],"Pieter":[588],"L.":[589],"Meenhorstb":[590],"Jan":[591],"Mulderb":[593],"Jos":[594],"H.":[595],"Beijnena":[596]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":18}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
